Choroideremia(CHM) is an X-linked chorioretinal dystrophy characterized by progressive degeneration of the choroid, retinal pigment epithelium and retina. This disease is caused by mutations in the X-linked CHM gene encoding a Ras-related GTPase Rab escort protein (REP)-1, which is extremely important for the retinal function. Choroideremia is characterized by extensive loss of all retinal layers in the eyes.
DelveInsight’s, “Choroideremia Pipeline Insight, 2021” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Choroideremia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Request for Free Sample Report: https://www.delveinsight.com/sample-request/choroideremia-pipeline-insight
Some of Choroideremia Companies are:
DelveInsight’s Choroideremia report covers around 50+ products under different phases of clinical development like
Choroideremia Key Products
Current Choroideremia Treatment Scenario and Choroideremia Emerging Therapies:
Table of Contents:
Introduction
Executive Summary
Choroideremia: Overview
Pipeline Therapeutics
• Comparative Analysis
Therapeutic Assessment
Choroideremia – DelveInsight’s Analytical Perspective
In-depth Commercial Assessment
Choroideremia Collaboration Deals
Late Stage Products (Phase III)
BIIB111: Biogen
Drug profiles in the detailed report…..
Early Stage Products (Phase I)
4D110: 4D Molecular therapeutics
Preclinical stage products
Metformin: Curative Biotechnology
Inactive Products
Choroideremia Key Companies
Choroideremia- Unmet Needs
Choroideremia- Market Drivers and Barriers
Choroideremia- Future Perspectives and Conclusion
Choroideremia Analyst Views
Appendix
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: +19193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/report-store/choroideremia-pipeline-insight